Long noncoding RNA Chast promotes cardiac remodeling
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Inhibition of the long noncoding RNA Chast prevents pressure overload–induced cardiac remodeling in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epigenetic manipulation through long non-coding RNAs, miRNA modulators, and other oligonucleotides has yielded promising outcomes in experimental settings.162–165”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [163]
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797 · cited 1×
“To generate cardiac pressure overload, male C57BL/6N mice (8 to 10 weeks old) were subjected to TAC as described previously (29).”
MethodRetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244 · cited 1×
“LncRNAs regulate pathways by diverse mechanisms including chromatin modification (3), transcriptional (4) and posttranscriptional regulation (5), and influencing subcellular trafficking (6, 7).”
BackgroundGenome Regulation by Long Noncoding RNAs
Rinn, J. L., & Chang, H. Y. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051410-092902 · Cited by 4,005 · cited 1×
“LncRNAs can function as guide strands influencing genes or proteins in trans (on distantly located genes) or in cis (on neighboring genes) (23).”
BackgroundOpen source clustering software
de Hoon, M. J. L., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,043
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
Kong, L., Zhang, Y., Ye, Z.-Q., Liu, X.-Q., Zhao, S.-Q., Wei, L., & Gao, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm391 · Cited by 2,803
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566 · cited 2×
“To determine whether Chast is regulated by NFAT activation, we tested Chast expression in hearts of calcineurin (Myh6-CnA) transgenic (TG) mice (15), where NFAT is constitutively active.”
BackgroundMethodLian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., Hsiao, C., Kamp, T. J., & Palecek, S. P. (2013) · Nature Protocols · doi:10.1038/nprot.2012.150 · Cited by 1,748
Cited by
Items 201–300 of 369
Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells
Uchida, S., & Bolli, R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7262 · Cited by 21
RNA therapeutics for heart disease
Majo, F. D., & Windt, L. J. D. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.037 · Cited by 21
Yuan, S., Zhang, X., Zhan, J., Xie, R., Fan, J., Dai, B., Zhao, Y., Yin, Z., Liu, Q., Wang, D. W., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2452-2 · Cited by 22
“Only 1.5% of the genome codes for proteins, with the rest either remaining untranscribed or expressing noncoding RNAs (Consortium, 2012; Viereck et al., 2016).”
InfluentialDysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients
Ebadi, N., Ghafouri‐Fard, S., Taheri, M. N., Arsang‐Jang, S., Parsa, S. A., & Omrani, M. D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172852 · Cited by 20
Epigenetic Regulation of Autophagy in Cardiovascular Pathobiology
Bu, S., & Singh, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126544 · Cited by 19
“Overexpression of Chast resulted in decreased Plekhm1 and cardiac autophagy, leading to cardiac hypertrophy in mice, and silencing Chast resulted in attenuated TAC-induced cardiac remodeling [86].”
BackgroundZhang, L., Salgado‐Somoza, A., Vausort, M., Leszek, P., & Devaux, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.11.002 · Cited by 20
Noncoding RNAs in exercise-induced cardio-protection for chronic heart failure
Ma, S., & Liao, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.051 · Cited by 19
“Moreover, cardiac hypertrophy-associated transcript (Chast) and cardiac hypertrophy-associated epigenetic regulator (Chaer) were also demonstrated to promote TAC-induced pathological hypertrophy by impeding autophagy and modifying epigenetic changes of hypertrophic genes respectively [36,37].”
BackgroundThe roles of non-coding RNAs in cardiac regenerative medicine
Choong, O. K., Lee, D. S., Chen, C.-Y., & Hsieh, P. C. H. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.06.001 · Cited by 19
Hu, F., Yang, J., Chen, X., Shen, Y., Chen, K., Fu, X., Guo, S., & Jiang, Z. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.03.015 · Cited by 16
Sumi, M. P., Mahajan, B., Sattar, R. S. A., Nimisha, Apurva, A., Kumar, A., Sharma, A. K., Ahmad, E., Ali, A., & Saluja, S. S. (2021) · Epigenetics Insights · doi:10.1177/2516865720988567 · Cited by 18
Sex-Based Mhrt Methylation Chromatinizes MeCP2 in the Heart
Kaipananickal, H., Okabe, J., Mathiyalagan, P., Khan, A. W., Jadaan, S. A., Sarila, G., Ziemann, M., Khurana, I., Maxwell, S., Du, X., et al. (2019) · iScience · doi:10.1016/j.isci.2019.06.031 · Cited by 16
Long Non-Coding RNAs as Key Regulators of Cardiovascular Diseases
Ono, K., Kuwabara, Y., Horie, T., & Kimura, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0169 · Cited by 17
Zhang, J., Feng, C., Song, C., Ai, B., Bai, X., Liu, Y., Li, X., Zhao, J., Shi, S., Chen, X., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13376 · Cited by 16
“[18] found that overexpression of lncRNA Chast could lead to CH in vitro and in vivo.”
BackgroundLi, X., Wang, H., Jiang, F., Sun, H., & Zhang, D. (2020) · Aging · doi:10.18632/aging.102668 · Cited by 16
“Chast induces cardiomyocyte autophagy and drives hypertrophy by inhibiting Plekhm1 expression [11].”
BackgroundRetractedReconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review
Shahzadi, S. K., Naidoo, N. S., Alsheikh-Ali, A. A. A., Rizzo, M., Rizvi, A. A., Santos, R. D., & Banerjee, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179378 · Cited by 15
“Chast Promotes cardiac hypertrophy by activating NFAT signaling and downregulates Plekhm1 to induce cardiac remodeling processes [47]”
BackgroundMetabolic Profiling Reveals Altered Tryptophan Metabolism in Patients with Kawasaki Disease
Fan, X., Li, K., Guo, X., Liao, S., Zhang, Q., Xu, Y., Cui, H., Zheng, L., & Xu, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1180537 · Cited by 17
“, 2015), and myocardial hypertrophy (Viereck et al., 2016), and has helped identify new biomarkers and therapeutic strategies.”
BackgroundAngiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism
Li, J., Jia, J., Dong, L., Hu, Z., Huang, X., Wang, H., Wang, L., Yang, S., & Lan, H. Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.017 · Cited by 16
Cytoplasmic sequestration of p53 by lncRNA-CIRPILalleviates myocardial ischemia/reperfusion injury
Jiang, Y., Yang, Y., Zhang, Y., Yang, J.-Q., Zhang, M.-M., Li, S., Xue, G., Li, X., Zhang, X., Yang, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03651-y · Cited by 16
Lu, Y., Fang, Q., Ming Xin, Q. I., Li, X., Zhang, X., Lin, Y., Xiang, Y., Fu, Q., & Wang, B. (2023) · Communications Biology · doi:10.1038/s42003-023-04565-z · Cited by 14
The role and medical prospects of long non-coding RNAs in cardiovascular disease
Kim, N., Chung, W., & Cho, J. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10342-1 · Cited by 14
Zhang, F., Liu, G., Bu, Y., Ma, X., & Hao, J. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.005 · Cited by 15
Linc- ing the Noncoding Genome to Heart Function: Beating Hypertrophy
Chatterjee, S., Bär, C., & Thum, T. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.007 · Cited by 14
Self-citationNon-coding RNAs and Pathological Cardiac Hypertrophy
He, J., Luo, Y., Song, J., Tan, T., & Zhu, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_13 · Cited by 13
lncRNA ZEB2‑AS1 stimulates cardiac hypertrophy by downregulating PTEN
Cheng, Z., Liu, L., & Li, Q. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9220 · Cited by 14
Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy
Makarewich, C. A., & Thum, T. (2022) · Circulation · doi:10.1161/circulationaha.122.059278 · Cited by 14
Self-citationLong non-coding RNAs in cardiac hypertrophy
Sun, J., & Wang, C. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09882-2 · Cited by 15
The Noncoding Side of Cardiac Differentiation and Regeneration
Pagano, F., Calicchio, A., Picchio, V., & Ballarino, M. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200123120249 · Cited by 13
LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?
Ren, K., Xu, X., Yu, X.-H., Li, M., Shi, M., Liu, Q.-X., Jiang, T., Zheng, X., Yin, K., & Zhao, G.-J. (2020) · Aging · doi:10.18632/aging.103786 · Cited by 13
“Similarly, the intraperitoneal injection of lncRNA Chast-targeted GapmeR into mice significantly ameliorates cardiac remodeling and hypertrophy through the suppression of Plekhm1 expression [95].”
BackgroundThe Functions of Long Non-Coding RNA (lncRNA) H19 in the Heart
Wang, Y., Sun, X., & Sun, X. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.10.022 · Cited by 13
Non-coding RNAs: Important participants in cardiac fibrosis
Dong, Y., Peng, N., Dong, L., Tan, S., & Zhang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.937995 · Cited by 15
“It can regulate hypertrophic genes through inhibiting Pleckstrin Homology Domain–containing Protein Family M Member 1 (PLEKHM1) and cardiac fibrosis via paracrine pathways (41).”
BackgroundWang, L., Ma, X., Xu, X., & Zhang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00823-3 · Cited by 13
Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer
Dashti, S., Ghafouri‐Fard, S., Esfandi, F., Oskooei, V. K., Arsang‐Jang, S., & Taheri, M. N. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104359 · Cited by 14
Long Noncoding RNAs in Cardiac Development
Alexanian, M., & Ounzain, S. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037374 · Cited by 16
Meybodi, S. M. E., Soleimani, N., Yari, A., Javadifar, A., Tollabi, M., Karimi, B., Meybodi, M. E., Seyedhossaini, S., Milan, P. B., & Firoozabadi, A. D. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.167 · Cited by 15
LncRNAs in Cardiomyocyte Maturation: New Window for Cardiac Regenerative Medicine
Kay, M., & Soltani, B. M. (2021) · Non-Coding RNA · doi:10.3390/ncrna7010020 · Cited by 13
“Maturation Characteristics LncRNA Function Regulated Target Ref Proliferation and hypertrophy Mhrt Hypertrophy regulation Hdac5 [91] Hypertrophy regulation/Myocd regulation miR-145-5p [92] H19 Hypertrophy regulation/NFAT signaling Prc2 [93] Mitochondria-mediated apoptosis regulation by PBX3-dependent way miR-675 CYP1B…”
Comparative Analysis of Non-Coding RNA Transcriptomics in Heart Failure
García‐Padilla, C., Lozano-Velasco, E., García‐López, V., Aránega, A. E., Franco, D., García‐Martínez, V., & López‐Sánchez, C. (2022) · Biomedicines · doi:10.3390/biomedicines10123076 · Cited by 14
Plumbing mysterious RNAs in “dark genome” for the conquest of human diseases
Huang, L. A., Lin, C., & Yang, L. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.05.003 · Cited by 13
An Overview of Non-coding RNAs and Cardiovascular System
Mushtaq, I., Ishtiaq, A., Ali, T., Jan, M. I., & Murtaza, I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_1 · Cited by 14
Shaharyar, M. A., Bhowmik, R., Al-Abbasi, F. A., AlGhamdi, S. A., Alghamdi, A. M., Sarkar, A., Kazmi, I. A., & Karmakar, S. (2023) · Vaccines · doi:10.3390/vaccines11020241 · Cited by 12
Cao, T., Zhang, S., Chen, Q., Zeng, C., Wang, L., Jiao, S., Chen, H., Zhang, B., & Cai, H. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.07.027 · Cited by 13
Zhang, Y., Zhao, J., Jin, Q., & Zhuang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052816 · Cited by 11
“Extensive investigations have consistently shown a compelling association between infrequent immune activation, immune cell infiltration [4], and the occurrence of cardiovascular diseases, most notably atherosclerosis, coronary heart disease, and heart failure [5,6].”
BackgroundLncRNA Tincr regulates PKCɛ expression in a miR-31-5p-dependent manner in cardiomyocyte hypertrophy
Li, H., Shi, H., Zhang, F., Xue, H., Wang, L., Tian, J., Xu, J., & Han, Q. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01847-9 · Cited by 11
Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
Silva, J., & Martins, P. A. D. C. (2022) · Cells · doi:10.3390/cells11111805 · Cited by 13
Rezaee, M., Masihipour, N., Milasi, Y. E., Dehmordi, R. M., Reiner, Ž., Asadi, S., Mohammadi, F., Khalilzadeh, P., Rostami, M., Asemi, Z., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230306143351 · Cited by 11
Jin, L., Hong, N., Ai, X., Wang, J., Li, Z., Han, Z., Zhang, Q., Yu, Y., & Sun, K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200320161835 · Cited by 12
DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer
Afrough, H., Ghafouri‐Fard, S., Yousefi, H., Pakzad, P., Oskooei, V. K., & Taheri, M. N. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104490 · Cited by 11
Bektik, E., Cowan, D. B., & Wang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155424 · Cited by 13
Long Non-coding RNA Based Therapy for Cardiovascular Disease
Quinones, N. B., Belluomo, R., Juni, R. P., & Boon, R. A. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10686-z · Cited by 13
The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling
Zhao, K., Mao, Y., Li, Y., Yang, C., Wang, K., & Zhang, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.952949 · Cited by 15
“Subsequent in vitro and in vivo functional studies support the role of Chast as an endogenous prohypertrophic lncRNA (106).”
BackgroundEpigenetics of cardiomyopathies: the next frontier
Hajdarpašić, A., Tukker, M., Rijdt, W. P. T., Mohamedhoesein, S., Meijers, W. C., & Çalişkan, K. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10460-4 · Cited by 13
Gu, Y., Yang, F., Xu, R., Zhang, Y., Li, Y., Liu, S., Zhang, G., Wang, G., & Ma, L. (2017) · Cell Biology International · doi:10.1002/cbin.10809 · Cited by 10
Strategies and technologies for exploring long noncoding RNAs in heart failure
Zhang, Z., Wan, J., Liu, X., & Zhang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110572 · Cited by 12
Single-cell transcriptomes in the heart: when every epigenome counts
Gromova, T., Gehred, N., & Vondriska, T. M. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac040 · Cited by 12
Aydinli, M., Liang, C., & Dandekar, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-21732-0 · Cited by 13
Self-citationMauro, V. D., & Catalucci, D. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.20 · Cited by 10
“, gapmers) has started to be used for different in vitro and in vivo studies (29,30), more efforts are still required for overcoming some obstacles for their exploitation in translational medicine.”
BackgroundPanoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine
Bergonzini, M., Loreni, F., Lio, A., Russo, M., Saitto, G., Cammardella, A. G., Irace, L., Tramontin, C., Chello, M., Lusini, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102864 · Cited by 13
Noncoding RNAs and Cardiac Fibrosis
Chang-yong, W., Bao, S., Li, R., Sun, H., & Peng, Y. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2402063 · Cited by 8
“…stenosis and negatively regulated protein family M member one of the pleckstrin homologous structural domains (in the strand opposite to that carrying Chast), impeding cardiomyocyte autophagy and hypertrophy, suggesting that Chast may be a potential target for preventing cardiac remodeling [59].”
BackgroundYang, G., & Yang, W. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1587124 · Cited by 10
“The lncRNA Mhrt and chromatin feedback loop are essential for cardiac function and the prevention of pathological hypertrophy, whereas the restoration of Mhrt expression safeguards against heart failure (Viereck et al., 2016; Goh et al., 2019).”
Nie, X., Fan, J., Wang, Y., Xie, R., Chen, C., Li, H., & Wang, D. W. (2024) · Frontiers of Medicine · doi:10.1007/s11684-023-1036-4 · Cited by 8
Kumar, A., Yap, K. C.-H., BharathwajChetty, B., Lyu, J., Hegde, M., Abbas, M., Alqahtani, M. S., Khadlikar, S., Zarrabi, A., Khosravi, A., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01092-9 · Cited by 12
Kong, Q., Zhou, J., Ma, C., Wei, Z., Chen, Y., Cheng, Y., Wu, W.-C., Zhou, Z., Tang, Y., & Liu, X. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106677 · Cited by 9
Qin, Y., Yan, G., Qiao, Y., Wang, D., Luo, E., Hou, J., & Tang, C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9293 · Cited by 8
Li, J., Xiao, F., Wang, S., Fan, X., He, Z., Yan, T., Zhang, J., Yang, M., & Yang, D. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.014 · Cited by 10
“3 Previous studies have shown that lncRNAs are key regulators of the occurrence and development of various diseases, including cancer, 4 cardiovascular disease, 5 and diabetic vascular complications.”
BackgroundLong Non-Coding RNAs in Cardiac Hypertrophy
Mangraviti, N., & Windt, L. J. D. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.836418 · Cited by 7
LincRNA RMRP Regulates Phenylephrine-induced Cardiomyocyte Hypertrophy by Means of Targeting miR-1
Chen, J., Li, J., Wang, X., Zeng, Z., Zhang, H., Zou, Z., Huang, N., & Sun, X. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001366 · Cited by 7
The role of ncRNA in the co-regulation of autophagy and exosome pathways during cancer progression
Soni, N., Nandi, G., Chaudhary, M., & Bissa, B. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119523 · Cited by 7
Xiong, Y., Alnoud, M. A. H., Ali, H., Ali, I., Ahmad, S., Khan, M. U., Hassan, S. S. U., Majid, M., Khan, M. S., Ahmad, R. U. S., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102390 · Cited by 7
Cardiovascular Risk Factors and Markers
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_2 · Cited by 9
SNHG16 accelerates the proliferation of primary cardiomyocytes by targeting miRNA‑770‑5p
Yang, L., Lu, Y., Ming, J., Pan, Y., Yu, R., Wu, Y., & Wang, T. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9083 · Cited by 7
“Recent studies have shown the involvement of lncRNAs in the regulation of cardiovascular disease (27,28).”
BackgroundLuo, C., Xiong, S., Huang, Y., Deng, M., Zhang, J., Chen, J., Yang, R., & Xiao, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.615950 · Cited by 7
Self-citationDeregulation of NF-κB associated long non-coding RNAs in bipolar disorder
Pirbalouti, R. G., Mohseni, M. M., Taheri, M. N., Neishabouri, S. M., & Shirvani-Farsani, Z. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01246-y · Cited by 8
Angom, R. S., Joshi, A., Patowary, A., Sivadas, A., Ramasamy, S., Vellarikkal, S. K., Kaushik, K., Sabharwal, A., Lalwani, M. K., Subburaj, K., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1339292 · Cited by 6
“Multiple studies have identi fi ed mammalian lncRNA repertoire associated with several cardiac pathophysiologies such as hypertrophy (Han et al., 2014; Viereck et al., 2016; Wang et al., 2016), ventricular septal defects (Song et al., 2013), myocardial infarction (Ounzain et al., 2015; Li et al.,…”
BackgroundLong non-coding RNAs: A crucial part of the vasculature puzzle
Garg, A., Gupta, S. K., & Thum, T. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.008 · Cited by 7
Self-citationA comprehensive method protocol for annotation and integrated functional understanding of lncRNAs
Kunz, M., Wolf, B., Fuchs, M., Christoph, J., Xiao, K., Thum, T., Atlan, D., Prokosch, H., & Dandekar, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz066 · Cited by 8
“We applied this analysis strategy as useful software and support in testing RNA functionalities for the hypertrophy associated lncRNA Chast [6] and human hypoxia-sensitive lncRNAs LINC00323–003 and MIR503HG [29].”
MethodSelf-citationTranslational Potential of Non-coding RNAs for Cardiovascular Disease
Ooi, J. Y. Y., & Bernardo, B. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_21 · Cited by 7
Ruidas, B., Michaud, W. A., Lindner, S. R., Tessier, S. N., Osho, A. A., & Rabi, S. A. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120669 · Cited by 6
Zhang, X., Feng, T., Zeng, X.-X. I., Liang, H., Situ, B., Zhang, Q., Zhou, F., Chen, Y., Wang, T., Cai, D., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.581362 · Cited by 6
“Although clinical anti-hypertensive drugs, including ACEI, ARB, and βblockers, have certain functions in inhibiting vascular remodeling while also reducing blood pressure, the clinical benefits of these drugs are not satisfactory (5).”
BackgroundFunctional genomics and epigenomics of atrial fibrillation
Victorino, J., Álvarez, A., & Manzanares, M. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.003 · Cited by 7
Up-regulated lncRNA SNHG9 mediates the pathogenesis of dilated cardiomyopathy via miR-326/EPHB3 axis
Zhang, F., Shi, H., Xue, H., Li, H., Li, C., & Han, Q. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02798-7 · Cited by 6
Role of non-coding RNAs in cardiotoxicity of chemotherapy
Song, L., Qiao, G., Xu, Y., Ma, L., & Jiang, W. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.06.003 · Cited by 6
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload
Kuwabara, Y., Tsuji, S., Nishiga, M., Izuhara, M., Ito, S., Nagao, K., Horie, T., Watanabe, S., Koyama, S., Kiryu, H., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01164-0 · Cited by 9
Translational Opportunities and Challenges of Long Noncoding RNAs in Cardiac Regeneration
Thum, T. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.039 · Cited by 6
“Cardiac hypertrophy–associated transcript (Chast) is a transcriptional target of the NFAT and is up-regulated in response to hypertrophic stimuli specifically in cardiomyocytes; its pharmacological inhibition blocks cardiac remodeling and hypertrophy in a transaortic constriction mouse model (5).”
BackgroundSelf-citationPan, W. Q., Hunkler, H. J., Chatterjee, S., Lu, D., Riedel, I., Gietz, A., Xiao, K., Fuchs, M., Neufeldt, D., Kraft, T., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05915-2 · Cited by 9
“Patients’ cardiac tissue was sampled with the approval of the institutional ethics committee of the Hannover Medical School, Germany complied with the 1964 Declaration of Helsinki and its amendments [34, 35].”
Self-citationRecent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies
Zhao, M., He, X., Min, X., Yang, H., Wu, W., Zhong, J., Xu, H., & Chen, J. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25132 · Cited by 6
LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway
Zhuo, S., Liu, Y., Wang, S., Chen, Z., Shi, X., Zhang, Y., Xu, D., Hu, J., Wang, Y., & Qu, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1538059 · Cited by 6
“…(LncRNA) refers to a class of RNA transcripts longer than 200 nucleotides that lack protein-coding capacity (Bridges et al., 2021), yet play a crucial regulatory role in cardiovascular diseases, as supported by substantial evidence (Holdt and Teupser, 2012; Qu et al., 2017; Viereck et al., 2016).”
Autophagy in striated muscle diseases
Bailin, P. L., Zhang, L., Zhang, L., & Han, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1000067 · Cited by 7
“Silencing of LncRNA Chast with ASO prevents and improves TAC-induced adverse cardiac remodeling without early signs of toxicity (86).”
BackgroundZhang, Z., Zhu, D., Shi, P., Wu, J., Li, F., & Chen, Y. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2194074 · Cited by 7
“LncRNA Chast accumulates in hypertrophic myocardium and accelerates autophagy of cardiomyocytes (Viereck et al., 2016).”
Nichtkodierende RNA: Innovative Regulatoren mit therapeutischer Perspektive
Bührke, A., Bär, C., & Thum, T. (2017) · Herz · doi:10.1007/s00059-017-4660-4 · Cited by 5
Self-citationIn Vivo Administration of Therapeutic Antisense Oligonucleotides
Statello, L., Ali, M. M., & Kanduri, C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1158-6_17 · Cited by 6
Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat modelPreprint
Centeno, M. V., Alam†, M. S., Haldar, K., & Apkarian, A. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.13.571583 · Cited by 5
Yu, T., Gao, Q., Zhang, G., Li, T., Liu, X., Li, C., Zheng, L., Sun, X., Wu, J., Cao, H., et al. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1065-7 · Cited by 5
Alimohammadi, M., Abolghasemi, H., Cho, W. C. S., Reiter, R. J., Mafi, A., Aghagolzadeh, M., & Hushmandi, K. (2025) · Medical Oncology · doi:10.1007/s12032-025-02710-8 · Cited by 5
“The Chast/Plekhm1 axis can regulate autophagosome merge with the lysosome [120].”
Diagnostic Modalities in Heart Failure: A Narrative Review
Tanisha, Amudha, C., Raake, M., Samuel, D., Aggarwal, S., Bashir, Z. M. D., Marole, K. K., Maryam, I., & Nazir, Z. (2024) · Cureus · doi:10.7759/cureus.67432 · Cited by 10
“…as a lucrative target in patients with aortic stenosis [37,97]. lncRNAs, cardiac hypertrophy-associated epigenetic regulator (CHAER) and cardiac hypertrophy-associated transcript (CHAST), have also been studied due to their potential epigenetic roles in manipulating hypertrophy genes [37,98,99].”
BackgroundNoncoding RNAs in the Cardiovascular System: Exercise Training Effects
Pereira, N. P., Gatto, C. D. V. G., de Oliveira, E. M., & Fernandes, T. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.86054 · Cited by 4
Nepali, K., Liou, J., Sharma, R., Sharma, S., Thakur, A., Singh, A., & Singh, J. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220217103441 · Cited by 4
Altered Long Non-coding RNA Expression in Cancer: Potential Biomarkers and Therapeutic Targets?
Hanly, D. J., Esteller, M., & Berdasco, M. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_83 · Cited by 4
Vascular Smooth Muscle Cell Remodeling: The GIVER Story
Fiedler, J., & Thum, T. (2018) · Circulation Research · doi:10.1161/circresaha.118.314184 · Cited by 3
Self-citationAzimi, T., Ghafouri‐Fard, S., Badrlou, E., Omrani, M. D., Nazer, N., Sayad, A., & Taheri, M. N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00778-5 · Cited by 3
Long Non-coding RNA Involved in the Pathophysiology of Atrial Fibrillation
Zhong, Z., Li, X., Gao, L., Wu, X. O., Ye, Y., Zhang, X., Zeng, Q., Zhou, C., Lu, X., Wei, Y. Q., et al. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07491-8 · Cited by 4
Chen, B., Lian, T., Wang, Y., Yang, L., Liu, J., Chen, D., Huang, S., Mao, F., & Lian, J. (2023) · Journal of Molecular Histology · doi:10.1007/s10735-023-10166-1 · Cited by 4
“LncRNA cardiac-hypertrophy-associated-transcript (CHAST) promotes hypertrophy by disrupting beneficial autophagic processes via down-regulation of Plekhm1 (Viereck et al. 2016). lncRNA HOTAIR functions as a negative regulator of CH (Lai et al. 2017).”
Background
Metadata
- Authors
- Viereck, J., Kumarswamy, R., Foinquinos, A., Xiao, K., Avramopoulos, P., Kunz, M., Dittrich, M., Maetzig, T., Zimmer, K., Remke, J., Just, A., Fendrich, J., Scherf, K., Bolesani, E., Schambach, A., Weidemann, F., Zweigerdt, R., de Windt, L. J., Engelhardt, S., Dandekar, T., Batkai, S., & Thum, T.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- German Centre for Cardiovascular Research (DE)
- University of Würzburg (DE)
- Department of Cardiology, Maastricht University, 6202 AZ Maastricht, Netherlands.
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Integriertes Forschungs- und Behandlungszentrum Transplantation (IFB-Tx), Hannover Medical School, D-30625 Hannover, Germany.
- Corresponding author
- Viereck, Janika
- Kumarswamy, Regalla
- Foinquinos, Ariana
- Thum, Thomas
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-02-17
- Volume
- 8
- Issue
- 326
- Pages
- 326ra22-326ra22
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2283987082
- Cited by
- 370
- References
- 44
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 20 · 2023: 35 · 2022: 35 · 2021: 32 · 2020: 58 · 2019: 56 · 2018: 45 · 2017: 43 · 2016: 15
- FWCI
- 43.72
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Integrierte Forschungs- und Behandlungszentrum Transplantation (BMBF 01EO1302)
- Deutsche Forschungsgemeinschaft (TH 903/10-1, RE 3523/1-1)
- REBIRTH Excellence Cluster
- Fondation Leducq
- European Research Council
- Hannover Biomedical Research School
- Bayerische Forschungsstiftung
- German Research Foundation (EXC62/3, ZW 64/4-1)
- German Ministry for Education and Science (13N12606)
- Innovative Medicines Initiative (115439-2)
- European Union (FP7/2007-2013)
- European Federation of Pharmaceutical Industries and Associations
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- long non-coding RNA, cardiac remodeling, cardiomyocyte hypertrophy, pressure overload, transverse aortic constriction, aortic stenosis, autophagy, PLSCR1, lncRNA expression profiling, heart disease
- MeSH terms
- Animals, Base Sequence, Gene Expression Regulation, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Pressure, Signal Transduction, Ventricular Remodeling, Myocytes, Cardiac, NFATC Transcription Factors, Translational Research, Biomedical, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.